<unk> , trademarked as Zantrene, is an anthracenyl bishydrazone with anthracycline-like antineoplastic activity.<unk>  intercalates with and disrupts the configuration of DNA, resulting in DNA single-strand breaks, DNA-protein crosslinking, and inhibition of DNA replication. This agent is similar to doxorubicin in activity, but unlike anthracyclines like doxorubicin, exhibits little cardiotoxicity.<unk>  has recently been identified a potent (IC50 142nM) Fat Mass and Obesity (FTO) associated protein a m6A RNA demethylase.<unk>  is currently undergoing a number of Phase II trials to assess the efficacy of fighting hard to target cancers and understand any negative side effects that could occur.
Bisantrene
Mebanazine
Amineptine
Fosaprepitant
Argyrol
Promazine
Nusinersen
Furegrelate